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SUMMARY
This study investigates the association between socio-economic deprivation and tuberculosis (TB)
treatment delays in England, 2000–2005. Patients reported to the Enhanced TB Surveillance
system were assigned a deprivation score based on residential postcode, and categorized into
deprivation quartiles. Data were analysed using Cox regression. The median interval from
symptom onset to treatment initiation was 67 days (inter-quartile range 30–131). The eﬀect of
deprivation on this interval was modiﬁed by ethnic group and place of birth/time since entry into
the United Kingdom. Longer intervals were experienced by the most deprived black Africans,
Indians/Pakistanis/Bangladeshis and recent entrants to the United Kingdom, compared to the
least deprived. In contrast, among white and UK-born patients, longer intervals were experienced
by the least deprived. In conclusion, the eﬀect of deprivation on TB treatment delays varies in
diﬀerent population groups. Eﬀorts are needed to reduce delays including improving awareness of
TB and increasing the index of clinical suspicion.
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INTRODUCTION
The fall in tuberculosis (TB) incidence in England
over the last century was, at least in part, due to
a reduction in levels of poverty and socio-economic
deprivation. TB has recently re-emerged as a serious
public health problem in England [1]. Control of TB is
founded on early diagnosis and treatment of active
cases and infected contacts. Delay in initiating treat-
ment not only impacts on TB control by increasing
the risk of disease transmission [2], but also adversely
aﬀects clinical outcomes including increasing the risk
of mortality [3–5]. The interval from symptom onset
to diagnosis and initiation of treatment among TB
cases presenting passively to health-care services is
inﬂuenced by a number of factors.
Most studies looking at factors associated with
treatment delay are from high prevalence countries
[6]. Studies from developed countries include those
from the United States [7–10], Japan [11], Canada
[12], and the United Kingdom [13–15]. Social and
cultural factors such as unemployment, cost of care,
lack of knowledge of health services, language bar-
riers, homelessness, and concerns regarding immi-
gration status, have been associated with delayed
access to care in developed countries [7, 9–11]. Earlier
studies from the United Kingdom have reported
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longer TB treatment delays among those of white
ethnicity, females, older patients, and those born
in low prevalence countries [13, 14]. None of these
studies examined the eﬀect of socio-economic depri-
vation on TB treatment delays.
Understanding the factors associated with TB
treatment delays, including potentially modiﬁable
factors such as socio-economic deprivation, is essen-
tial for eﬀective disease control. This analysis of
national surveillance data, therefore, aims to investi-
gate whether there is an association between an eco-
logical measure of socio-economic deprivation and
the interval from symptom onset to initiation of TB
treatment.
METHODS
Data sources
Information on TB cases reported to the Enhanced
Tuberculosis Surveillance (ETS) system for England
during the period 2000–2005 was analysed. This
national surveillance system collects information on
the demographic and clinical characteristics of TB
cases. Details of the system have been published else-
where [1].
The index of multiple deprivation (IMD) provides
deprivation scores for small census areas in England
(Lower Super Output Areas). IMD scores are a com-
posite measure based on seven dimensions of depri-
vation (income, employment, health and disability,
education, skills and training, barriers to housing and
services, living environment and crime) [16]. MapInfo
Professional (version 8.0) was used to assign a depri-
vation score, based on residential postcode, to each
patient using the 2004 IMD. Patients were then cat-
egorized into quartiles of deprivation according to
their IMD score.
Deﬁnitions
TB cases were either those with culture-conﬁrmed
disease due to Mycobacterium tuberculosis complex
(M. tuberculosis, M. bovis or M. africanum) or other
cases meeting the following criteria: (a) a clinician’s
judgement that the patient’s clinical or radiological
signs are compatible with TB and (b) the clinician’s
decision to treat the patient with a full course of anti-
TB treatment.
The interval to start of treatment was deﬁned as the
total number of days between onset of symptoms (as
reported by the patient) and date of start of treatment,
or, if this was missing, date of diagnosis. Since the
ETS system does not collect information on the date
that patients ﬁrst present to health-care services, it
was not possible to separate patient delays (i.e. delay
from onset of symptoms to presentation to health-
care services), from health-care delays (i.e. delay from
patient presentation to initiation of treatment).
Ethnic groups were based on the Oﬃce of National
Statistics (ONS) classiﬁcations. Recent UK entrants
were deﬁned as those born abroad who entered the
United Kingdom <2 years prior to being diagnosed
with TB.
Statistical analysis
Median intervals and inter-quartile ranges (IQRs)
were calculated by deprivation score quartile and
by age group, sex, ethnic group, place of birth/time
since entry into the United Kingdom, site of disease,
and previous TB diagnosis. Cox proportional hazards
regression was used to investigate the association
between the interval to treatment and each of these
variables. The likelihood ratio (LR) test was used to
assess interactions between deprivation and each
other variable. Multivariable Cox proportional haz-
ards models adjusted for age and gender were strati-
ﬁed by those variables found to signiﬁcantly modify
the eﬀect of deprivation on the interval to initiation of
treatment. A hazard ratio (HR)<1 indicates a longer
interval. Data were analysed using Stata statistical
software, version 9 [17].
Ethics approval
The Health Protection Agency has Patient Infor-
mation Advisory Group approval to hold and analyse
national surveillance data for public health purposes
under Section 60 of the Health and Social Care Act
2001. Strict conﬁdentiality of all data is maintained.
RESULTS
Study population
A total of 40 779 TB cases were reported to the ETS
system in England during 2000–2005. The interval to
start of treatment could be derived for 56% (22 856)
of these. The median age of this study population was
36 years (IQR 26–54), 55% were male, and 68% were
non-UK born (Table 1).
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Cases without information available on the interval
to start of treatment were similar to the study popu-
lation in terms of age (median age 35 years, IQR
25–54) and gender (55% male). They did, however,
diﬀer slightly by level of deprivation (of those missing
data on interval to treatment, 22% were in the least
deprived quartile compared to 27% of the study
population).
Interval to start of treatment
The overall median interval to start of treatment
for the population was 67 days (IQR 30–131). The
interval was similar among those living in the four
deprivation quartiles, although slightly longer among
the least deprived and most deprived compared to
those in the middle two quartiles. Longer intervals
were experienced by older patients, females, those of
white ethnicity, those born in the United Kingdom
or born abroad with UK entry o2 years prior to TB
diagnosis, patients with extra-pulmonary disease, and
those with a previous TB diagnosis (Table 1).
Eﬀect of socio-economic deprivation on the interval
to start of treatment
There was strong evidence that the eﬀect of depri-
vation on the interval to initiation of treatment was
Table 1. Median intervals and univariable hazard ratios for the association between tuberculosis (TB) case
characteristics and the interval to initiation of TB treatment
Case characteristic
No. of
cases* (%)
Median interval
in days (IQR) HR (95% CI)# P value
Total 22 856 (100) 67 (30–131) — —
Deprivation quartile
1 (least deprived) 5925 (27.1) 70 (31–137) Ref. <0.001
2 5226 (23.9) 66 (29–128) 1.04 (1.00–1.08)
3 5063 (23.2) 65 (28–124) 1.07 (1.03–1.11)
4 (most deprived) 5633 (25.8) 71 (32–134) 1.00 (0.96–1.04)
Age group (years)
0–14 1088 (4.8) 37 (12–89) 1.40 (1.31–1.49)
15–44 13 463 (58.9) 66 (30–126) Ref. <0.001
45–64 4601 (20.1) 77 (35–148) 0.87 (0.84–0.90)
o65 3703 (16.2) 71 (31–142) 0.92 (0.89–0.95)
Sex
Male 12 491 (54.7) 65 (30–123) Ref. <0.001
Female 10 340 (45.3) 71 (31–140) 0.90 (0.87–0.92)
Ethnic group
White 6030 (26.7) 75 (33–145) 0.97 (0.94–1.00)
Black Caribbean 513 (2.3) 67 (31–137) 0.99 (0.90–1.08)
Black African 4536 (20.1) 58 (26–109) 1.20 (1.16–1.25)
Indian/Pakistani/Bangladeshi 9219 (40.8) 71 (32–135) Ref. <0.001
Other 2284 (10.1) 61 (24–121) 1.09 (1.04–1.14)
Place of birth/time since UK entry
Born in the UK 6954 (32.2) 70 (31–137) Ref. <0.001
Born abroad, UK entry<2 years ago 3022 (14.0) 59 (26–111) 1.17 (1.12–1.22)
Born abroad, UK entryo2 years ago 9543 (44.3) 72 (34–138) 0.98 (0.95–1.01)
Born abroad, year of entry missing 2047 (9.5) 57 (21–112) 1.17 (1.11–1.23)
Site of disease
Extra-pulmonary 9370 (41.1) 76 (34–153) Ref. <0.001
Sputum smear positive pulmonary 5683 (25.0) 61 (27–110) 1.35 (1.30–1.39)
Other pulmonary 7723 (33.9) 64 (28–122) 1.24 (1.20–1.27)
Previous TB diagnosis
No 18 739 (91.0) 69 (31–132) Ref. 0.047
Yes 1864 (9.0) 71 (32–140) 0.95 (0.91–1.00)
HR, Hazard ratio ; IQR, inter-quartile range ; CI, conﬁdence interval.
* Sum of numbers for each characteristic will not equal the total due to missing information.
# HR<1 indicates a longer interval.
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modiﬁed by ethnic group (LR test, P=0.004) and by
place of birth/time since entry into the UK (LR test,
P=0.002). Therefore, for further analyses, the eﬀect
of deprivation on the interval to start of treatment
was stratiﬁed by these variables.
After adjusting for age and sex, longer intervals
were experienced by the most deprived black Africans
[adjusted hazard ratio (aHR) 0.84, 95% conﬁ-
dence interval (CI) 0.77–0.92, P<0.001], Indians/
Pakistanis/Bangladeshis (aHR 0.93, 95% CI 0.88–
0.99, P=0.014), and recent UK entrants (aHR 0.88,
95% CI 0.79–0.97, P=0.012) compared to the least
deprived (Table 2). In contrast, among white and UK-
born patients, shorter intervals were experienced by
the most deprived (aHR 1.09, 95% CI 1.01–1.17 and
aHR 1.08, 95% CI 1.01–1.16, respectively) (Table 2).
DISCUSSION
TB patients in England experience a median interval
of 67 days from onset of symptoms to start of treat-
ment. This interval falls within the range observed
in previous studies in England [13–15], and other
developed countries [9, 18, 19]. There is currently no
consensus as to what is considered as an ‘acceptable’
interval although 30 days has been suggested [18]. The
substantial interval observed here is therefore of
concern.
Although overall there was little evidence of an
association between deprivation and interval to
treatment on univariable analysis, this did vary by
ethnic group and place of birth/time since UK entry.
The particularly long median intervals observed
among the least deprived white and UK-born patients
[82 days (IQR 36–158) and 77 days (IQR 33–152),
respectively] are of concern, and may be due to the
lower index of clinical suspicion of TB (compared to
that among the most deprived patients in these
population groups). The longer intervals observed
among the most deprived black Africans, Indians/
Pakistanis/Bangladeshis and recent UK entrants may
be related to language barriers, lack of knowledge
of health services, or issues related to immigration
status. Such factors have been found to be associated
with treatment delays elsewhere [7, 9, 10]. These
deprived population groups may also experience
barriers to accessing care, for example, diﬃculties
registering with a general practitioner [20].
In this study, longer intervals were also found to
be associated with older age, female gender, having
extra-pulmonary disease, and having had a previous
TB diagnosis. However, the actual diﬀerences in me-
dian delays between some of these groups were quite
small and may therefore not be of public health sig-
niﬁcance. The longer intervals among the elderly
could be explained by the higher frequency of co-
morbidities in this group which can complicate TB
diagnosis [14]. Meanwhile, the longer intervals ex-
perienced by the middle-aged population could be
related to factors such as place of birth and ethnic
Table 2. Median intervals and adjusted hazard ratios for the interval to initiation of tuberculosis treatment in
patients living in the most deprived areas compared to those in the least deprived, stratiﬁed by ethnic group and place
of birth/time since entry into the United Kingdom
Case characteristic
Median interval
among least deprived
in days (IQR)
Median interval
among most deprived
in days (IQR) aHR (95% CI)*# P value
Ethnic group
White 82 (36–158) 73 (34–136) 1.09 (1.01–1.17) 0.023
Black Caribbean 80 (36–173) 73 (37–139) 1.05 (0.80–1.39) 0.706
Black African 53 (24–101) 65 (30–121) 0.84 (0.77–0.92) <0.001
Indian/Pakistani/Bangladeshi 68 (31–132) 75 (35–143) 0.93 (0.88–0.99) 0.014
Other 61 (24–121) 65 (28–122) 0.95 (0.84–1.07) 0.391
Place of birth/time since UK entry
Born in the UK 77 (33–152) 64 (31–126) 1.08 (1.01–1.16) 0.026
Born abroad, UK entry<2 yr ago 56 (26–107) 67 (31–122) 0.88 (0.79–0.97) 0.012
Born abroad, UK entry>2 yr ago 73 (35–140) 76 (37–144) 0.94 (0.89–1.00) 0.049
Born abroad, year of entry missing 53 (19–113) 64 (28–125) 0.95 (0.84–1.08) 0.475
aHR, Adjusted hazard ratio ; CI, conﬁdence interval.
* aHR<1 indicates a longer interval.
# Adjusted for age and sex.
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group, or possibly social factors such as homelessness,
imprisonment or drug use [21]. Longer intervals
among females have been observed previously [13].
Patients with extra-pulmonary TB experienced longer
intervals compared to those with pulmonary disease.
However, a 61-day median interval was observed
among sputum smear-positive pulmonary cases which
is of particular concern in terms of potential trans-
mission of TB. The identiﬁcation and implementation
of methods to reduce these intervals should be ad-
dressed as a priority for TB control.
It was not possible to separate patient delays from
health-care delays. Such information would be useful
in interpreting the associations observed in this study.
There will be diﬀerences in both the duration of, and
reasons for, these two aspects of delay. For example,
patient delays may be due to social and behavioural
factors such as health-care-seeking behaviours, aware-
ness of TB and its symptoms, cultural norms, per-
ceived stigma, and access to services. In addition,
biological factors such as severity of symptoms will
also play a role. Meanwhile, health-care delays may
relate to the clinician’s index of suspicion/awareness
of TB, access to diagnostic facilities, referral pro-
cedures and other organizational factors. The collec-
tion of data that allows the separation of patient
delays from health-care delays is an important con-
sideration for future surveillance.
The IMD score is an ecological measure of depri-
vation and was used as a proxy for individual levels
of deprivation. There will be some misclassiﬁcation
of an individual’s level of deprivation using an
area measure, e.g. there may be some clustering of
certain population subgroups in geographical areas.
Consequently, the association between deprivation
and treatment delays may have been underestimated
in this study [22, 23]. It is also diﬃcult to disentangle
the eﬀects of an individual’s level of deprivation
from the eﬀects of the level of deprivation of the
area in which they live, e.g. availability of health-care
services. However, the IMD score is a composite
deprivation measure, and its domains have been
correlated to other health indicators such as mortality
[23] and life expectancy [24].
Other limitations of this study are that 44% of
cases were missing information on the interval to start
of treatment which may have introduced some selec-
tion bias. Cases with missing information were, how-
ever, similar to those with information in terms of
age and gender. Date of onset of symptoms was self-
reported and may therefore lack accuracy. Finally,
not all patients have a postcode of residence, in par-
ticular, deprived groups such as the homeless. How-
ever, only a small proportion of cases (4.6%) could
not be assigned a deprivation score.
CONCLUSION
The association between deprivation and TB treat-
ment delay in some population groups demonstrates
that deprivation is still playing a role in the epidemi-
ology of TB in England today. The overall median
delay of 67 days is substantial, and delays need to be
minimized for all patients. Particular eﬀorts may be
needed among certain population groups especially
the least deprived white and UK-born populations,
and also the most deprived minority ethnic popu-
lations and recent UK entrants. Prompt diagnosis
and initiation of eﬀective anti-TB treatment is a key
element of TB control, and any inequities in this need
to be addressed. Improving awareness of TB, ensuring
better access to health care, and increasing the clinical
index of suspicion of TB among certain population
groups and their health-care providers, should help
reduce delays.
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